Balyasny Asset Management LLC Bio N Tech Se Call Options Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$78.36 - $124.66 $23.6 Million - $37.6 Million
301,300 New
301,300 $35.8 Million
Q3 2023

Nov 14, 2023
SELL
$98.5 - $125.08 $6.4 Million - $8.13 Million
-65,000 Reduced 33.33%
130,000 $14.1 Million
Q2 2023

Aug 14, 2023
BUY
$102.58 - $129.66 $20 Million - $25.3 Million
195,000 New
195,000 $21 Million
Q3 2020

Nov 16, 2020
BUY
$57.81 - $104.17 $4.05 Million - $7.29 Million
70,000 Added 63.64%
180,000 $12.5 Million
Q2 2020

Aug 14, 2020
BUY
$38.58 - $66.74 $4.24 Million - $7.34 Million
110,000 New
110,000 $7.34 Million

Others Institutions Holding BNTX

# of Institutions
357
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email